19 Hrs_1777294237270_124456903.png&w=64&q=75)
Source:
الوطن
الوطن
Ready to play
Ready to play
A British study involving 77 men with advanced prostate cancer found that a blood test for tumor DNA may help identify those most likely to benefit from targeted radiation. The median time without disease progression was 7.8 months for men whose blood showed no tumor DNA, compared with 3 months for those whose blood did. After six months, the disease had not progressed in 58% of the first group, versus about 21% of the second. The researchers suggest that the presence of this genetic material may indicate cancer activity that medical imaging does not detect.
Notice: This Is an AI-Generated Summary
Comments (0)